Your session is about to expire
← Back to Search
Exercise for ADHD in College Students
N/A
Recruiting
Led By Cynthia M Hartung, Ph.D.
Research Sponsored by University of Wyoming
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up completed the day after each experimental appointment over a period of two weeks
Awards & highlights
No Placebo-Only Group
Summary
This trialwill study if physical exercise can be an effective treatment for college students with ADHD with the potential to improve cognitive functioning while providing ancillary health benefits.
Who is the study for?
This trial is for college students aged 18-29 at the University of Wyoming or Laramie County Community College who have ADHD. It's not for those with hyperactive/impulsive ADHD, pregnant women, people who can't walk without help, those told by a doctor to avoid exercise, anyone with conditions like heart disease that make exercise risky, or if they're on meds that affect thinking.
What is being tested?
The study tests how sprint interval training (SIT) affects attention and memory in students with ADHD compared to non-ADHD peers. The idea is that SIT might improve cognitive functions right after exercising. Participants will be divided into groups based on having ADHD or not, gender, and whether they exercised or didn't.
What are the potential side effects?
Since the intervention involves physical exercise (sprint interval training), potential side effects may include typical post-exercise symptoms such as muscle soreness, fatigue, and shortness of breath but no significant health risks are expected.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ completed at each experimental appointment over a period of two weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~completed at each experimental appointment over a period of two weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Continuous Performance Test (CPT) from appointment 1 to 2
Change in Digit Span from appointment 1 to 2
Change in Letter-Number Sequencing from appointment 1 to 2
+1 moreSecondary study objectives
Barkley Adult ADHD Rating Scale-Modified (BAARS-M)
Depression, Anxiety, and Stress Scale-Modified (DASS-M)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Sprint Interval TrainingExperimental Treatment1 Intervention
Participants will be scheduled for two in-lab experimental appointments: sprint interval training (SIT) and Non-SIT. During the SIT appointment, the researcher will lead the participant through a set of stretches and three minutes of low-intensity cycling on a Schwinn AD2 Airdyne leg-cycling and arm-cranking ergometer to warm up and increase blood flow to active muscles. Participants will then complete 16 minutes of SIT, consisting of eight bouts of 20 seconds of cycling followed by 100 seconds of rest. Participants will complete computer-based tests of sustained attention and working memory during both the SIT (15 minutes following the exercise) and Non-SIT appointments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sprint Interval Training
2021
N/A
~140
Find a Location
Who is running the clinical trial?
University of WyomingLead Sponsor
18 Previous Clinical Trials
1,488 Total Patients Enrolled
1 Trials studying Working Memory
40 Patients Enrolled for Working Memory
Cynthia M Hartung, Ph.D.Principal Investigator - University of Wyoming
University of Wyoming
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Working Memory
40 Patients Enrolled for Working Memory
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You primarily have hyperactive and impulsive symptoms of ADHD, which is uncommon in adults.You have a medical or genetic condition that puts you at high risk of physical activity-related health problems, such as heart or lung disease.You are taking medications that can affect your ability to think clearly (such as sedatives or antipsychotics).You have had a stroke or an aneurysm in the past.
Research Study Groups:
This trial has the following groups:- Group 1: Sprint Interval Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.